Home > Healthcare > Medical Services > Assisted Reproductive Technology (ART) Market

Assisted Reproductive Technology (ART) Market Share

Report ID: GMI506
Published Date: May 2024
Report Format: PDF

Download Free Sample

Assisted Reproductive Technology Market Share

The assisted reproductive technology industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive products and procedures with improved efficiency and affordability. This includes advancements in catheters, needles, media, incubators, and vitrification devices. Competition is driven by factors such as the quality, reliability, performance, cost, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.

Assisted Reproductive Technology Market Companies

Some of the eminent market participants operating in the assisted reproductive technology industry (ART) include:

Esco Micro Pte. Ltd
Gynotec
Hamilton Thorne Ltd.
Indira IVF Hospital Private Limited
Ivy Fertility
Kitazato Corporation
Laboratoire CCD
Liverpool Partners Group
Merck KGaA
MISTRAL FERTILITY CLINICS S.L.
NidaCon International AB
Sumitomo Mitsui Financial Group, Inc.
The Cooper Companies, Inc.
Thermo Fisher Scientific Inc.
Vitrolife Group
Western Fertility Institute

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Assisted reproductive technology market size was USD 34.7 billion in 2023 and is expected to register 6.9% CAGR from 2024-2032 owing to the rising prevalence of infertility across the population base worldwide.

Assisted reproductive technology industry from the procedure segment is expected to reach USD 58.6 billion by 2032 due to rising prevalence of infertility owing to various factors such as lifestyle changes, environmental factors, and delaying childbirth.

The U.S. assisted reproductive technology industry is expected to register 6.5% CAGR from 2024-2032 due to the increasing percentage of IVF delivery rate/cycle and rising number of patients adopting the ART procedures in the region.

Merck KGaA, MISTRAL FERTILITY CLINICS S.L., NidaCon International AB, Sumitomo Mitsui Financial Group, Inc., The Cooper Companies, Inc., Thermo Fisher Scientific Inc., Vitrolife Group, and Western Fertility Institute, are some of the major assisted reproductive technology companies worldwide.